How IGF-1 LR3 Affects HbA1c

HbA1c reflects average glucose over roughly 90 days, so it integrates the net metabolic effect rather than the acute swings:

1. Acute vs chronic divergence: each LR3 injection lowers glucose acutely, but chronic supraphysiological IGF-1 desensitises insulin signalling and tends to raise ambient glucose over time. HbA1c captures the chronic direction, not the post-injection dip.
2. The acromegaly model: chronic IGF-1 excess produces abnormal glucose tolerance in more than half of patients, with HOMA-IR tracking IGF-1 levels (Stelmachowska-Banas et al., 2009; Mori et al., 2013). A creeping HbA1c is the integrated version of that.
3. Slow to move: HbA1c lags fasting glucose and insulin, so it is a confirmation marker, not an early one.
4. No direct haemoglobin effect: IGF-1 LR3 does not alter red cell lifespan in a way that distorts HbA1c, so the reading is a faithful glucose average.

Realistic expectation:

• In a metabolically healthy athlete on a short 4-6 week cycle, HbA1c may move little, because it integrates slowly and the cycle is short
• The concern is the creep: an HbA1c drifting up toward or past 5.7% (the prediabetes threshold) signals that chronic IGF-1 exposure, often stacked with GH or insulin, is costing you glucose control

What it confirms: a rising HbA1c alongside a rising properly-timed HOMA-IR confirms genuine insulin resistance, cutting through the artefactually low on-cycle insulin numbers.

Threshold: HbA1c above 5.7% is prediabetes; above 6.5% is diabetic range and a hard reason to stop and reassess.

Timing: HbA1c at baseline and again at the 8-12 week mark. Testing it more often than every 8-12 weeks is wasteful because it moves slowly.

Read it as confirmation: use fasting glucose and off-cycle HOMA-IR for the early reads, and use HbA1c to confirm whether the chronic trend held over the quarter.

Stable is a win: if you are running LR3 (often alongside GH or insulin), an HbA1c that holds flat across the cycle is a meaningful result, not a null one.

Confounders: recent blood donation, haemolysis, or iron-deficiency correction can distort HbA1c. Interpret alongside the rest of the metabolic panel.

Add HbA1c to the panel: many bodybuilding panels skip it, which is a mistake on a compound that drives chronic insulin resistance. It is the best slow-integrating guardrail.

If HbA1c climbs: look hard at the whole stack. LR3 plus GH plus a bulk plus insulin is a lot of simultaneous glucose pressure. Dose reduction, carbohydrate management, and zone 2 cardio are the first levers; metformin or berberine with physician input if it keeps rising.

Confirm persistence post-cycle: retest HbA1c a few weeks after stopping to see whether glucose control recovers.

Do not be reassured by on-cycle insulin: HbA1c and off-cycle HOMA-IR are the honest markers; the on-cycle fasting insulin is not.